Total Payments
$16,939
2024 Payments
$2,485
Companies
36
Transactions
857
Medicare Patients
197
Medicare Billing
$23,390
Payment Breakdown by Category
Food & Beverage$16,681 (98.5%)
Education$258.23 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,681 | 846 | 98.5% |
| Education | $258.23 | 11 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. | $1,394 | 49 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,387 | 85 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,316 | 69 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,129 | 45 | $0 (2024) |
| Alkermes, Inc. | $1,113 | 50 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,033 | 49 | $0 (2024) |
| Allergan, Inc. | $1,020 | 93 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $1,002 | 72 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $961.01 | 43 | $0 (2024) |
| ABBVIE INC. | $947.63 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,485 | 102 | ABBVIE INC. ($377.53) |
| 2023 | $3,906 | 177 | ITI, Inc. ($688.02) |
| 2022 | $2,818 | 149 | ITI, Inc. ($658.84) |
| 2021 | $355.33 | 7 | Supernus Pharmaceuticals, Inc. ($176.65) |
| 2020 | $876.52 | 54 | Vanda Pharmaceuticals Inc. ($159.22) |
| 2019 | $3,063 | 172 | Allergan Inc. ($403.72) |
| 2018 | $1,763 | 100 | Allergan Inc. ($299.17) |
| 2017 | $1,672 | 96 | Sunovion Pharmaceuticals Inc. ($304.88) |
All Payment Transactions
857 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: CNS | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $4.99 | General |
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $138.88 | General |
| 06/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $55.56 | General |
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $99.99 | General |
| 04/19/2024 | Vertical Pharmaceuticals, LLC | Relexxii (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Neurology - ADHD medication | ||||||
| 04/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Neurology | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.03 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 04/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.89 | General |
| Category: PSYCHIATRY | ||||||
| 04/10/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 69 | 212 | $28,750 | $8,480 |
| 2021 | 2 | 68 | 196 | $26,150 | $8,389 |
| 2020 | 2 | 60 | 183 | $22,900 | $6,522 |
Total Patients
197
Total Services
591
Medicare Billing
$23,390
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 122 | $15,250 | $4,597 | 30.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 29 | 90 | $13,500 | $3,882 | 28.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 130 | $16,250 | $5,402 | 33.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 27 | 66 | $9,900 | $2,987 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 121 | $14,400 | $3,754 | 26.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 22 | 62 | $8,500 | $2,768 | 32.6% |
About Dr. Dharmesh Sheth, MD
Dr. Dharmesh Sheth, MD is a Psychiatry healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265493555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dharmesh Sheth, MD has received a total of $16,939 in payments from pharmaceutical and medical device companies, with $2,485 received in 2024. These payments were reported across 857 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($16,681).
As a Medicare-enrolled provider, Sheth has provided services to 197 Medicare beneficiaries, totaling 591 services with total Medicare billing of $23,390. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Long Beach, CA
- Active Since 03/28/2006
- Last Updated 06/30/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1265493555
Products in Payments
- VRAYLAR (Drug) $1,968
- CAPLYTA (Drug) $1,674
- REXULTI (Drug) $1,529
- LATUDA (Drug) $1,002
- INGREZZA (Drug) $961.01
- ARISTADA (Drug) $923.14
- AUSTEDO (Drug) $792.71
- SPRAVATO (Drug) $678.00
- Fanapt (Drug) $502.03
- HETLIOZ (Drug) $496.36
- Adzenys XR-ODT (Drug) $482.35
- Trintellix (Drug) $473.53
- UZEDY (Drug) $405.01
- JORNAY PM (Drug) $395.36
- Auvelity (Drug) $316.23
- Azstarys (Drug) $278.53
- ABILIFY MYCITE (Drug) $252.26
- TRINTELLIX (Drug) $250.20
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $247.00
- INVEGA SUSTENNA (Drug) $243.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Long Beach
Dr. Armen Goenjian, Md, MD
Psychiatry — Payments: $187,424
Psychiatry $187,424
Dr. Haig Goenjian, Md, MD
Psychiatry — Payments: $23,747
Psychiatry $23,747
Dr. Jay Lentzner, M.d, M.D
Psychiatry — Payments: $19,525
Psychiatry $19,525
Dr. James Jen Kin, Md, MD
Psychiatry — Payments: $16,619
Psychiatry $16,619
Dr. Christopher Reist, Md, MD
Psychiatry — Payments: $13,323
Psychiatry $13,323
Sabrina Sandoval, M.d, M.D
Psychiatry — Payments: $9,874
Psychiatry $9,874